baber/WOPTO huggingface dataset:
Patent CY-1107662-T1 (CY)
Title: Μεθοδος παρασκευης της (ε, ζ) 3-(2-aminoethoxyimino)-androstane-6,17-dione και αναλογων της
Inventor: GOBBINI MAURO
IPC: C07J51/00
Filed: 2007-05-09
Abstract: Περιγράφεται μια βελτιωμένη μέθοδος για την παρασκευή ενώσεων με το γενικό τύπο (I) και ειδικότερα για την παρασκευή της ένωσης (Ε,Ζ)-3-(2-aminoethoxyimino)androstane-6,17-dione, στην οποία n = 1, και R1 = R2= Η.
Patent CY-1107790-T1 (CY)
Inventor: BALLESTRAZZI ARIS
IPC: B65B27/08
Filed: 2007-11-07
Abstract: The device is mounted downstream of the sheet placers (14,14',14) to bring an engaging component (16) into contact with the front end of a fed product (13,13',13) during forward travel, align the product with a respective pusher (12), and then move away from the product to permit its travel towards a packaging area or towards another sheet placer. The products of any thickness or size are fed using the sheet placers to a conveyor (11) equipped with several pushers. The products are positioned one behind the other with a step that can be preset, and are stacked on top of each other for transfer to the packaging area. The products are wrapped in plastic film or paper in the packaging area. An independent claim is included for the alignment method for products fed into an automatic packaging machine.
Patent CY-1107522-T1 (CY)
Inventor: MOULSLEY TIMOTHY J
IPC: H04B7/005
Filed: 2007-12-17
Abstract: In a mobile communication system comprising a base station (100) and a plurality of mobile stations (200) and operating closed loop transmitter power control, power control commands for transmission on an uplink are derived from measurements made on received downlink signals comprising non-predetermined data values. Optionally the non-predetermined data values may comprise power control commands for uplink transmit power control.
Patent CY-1108371-T1 (CY)
Title: 1-φαινυλ και 1-πυριδυλπυραζολιου παραγωγα και χρηση αυτων ως ζιζανιοκτονα
Inventor: SCHNATTERER STEFAN
IPC: C07D231/44
Filed: 2008-09-24
Abstract: Η εφεύρεση αφορά παράγωγα 1-(2,4,6-τριϋποκατεστημένου-φαινυλ)-5-αμινο-4-υποκατεστημένου πυραζολίου του τύπου (Ι) ή άλατα αυτών, όπου τα διάφορα σύμβολα είναι όπως ορίζεται στη περιγραφή, μεθόδους για τη παρασκευή αυτών, συνθέσεις αυτών και χρήση αυτών για τον έλεγχο επιβλαβών (συμπεριλαμβανομένων αρθροπόδων και ελμίνθων).
Patent CY-1109802-T1 (CY)
Inventor: JORDAN FRÉDÉRIC
IPC: H04N1/32
Filed: 2009-01-30
Abstract: Example embodiments relate to a method for applying a special mark, that is invisible to the naked eye, on a medium. That is, the example embodiments provide a method for generating and applying on a medium a digital spatial mark of XxY dots in accordance with a resolution of d1x by d1y dots per surface unit, provided that the ratio d1x/d2x and or d1y/d2y is more than 1. The method further includes over-sampling the digital spatial mark in X based on a factor nx=d1x/d2x and in Y based on a factor ny=d1y/d2y; eroding the dots to be applied so as to leave one dot every nx dots in X and one dot every nx dots in Y; and applying the spatial mark on the support.
Patent CY-1115926-T1 (CY)
Title: Απεικονιση μυοκαρδιακης αιματωσης χρησιμοποιωντας αγωνιστες υποδοχεα αδενοσινης
Inventor: BELARDINELLI LUIZ
IPC: A61K31/00
Filed: 2013-10-16
Abstract: Μέθοδος αιμάτωσης μυοκαρδίου που επιτυγχάνεται χορηγώντας έναν ή περισσότερους αγωνιστές υποδοχείς αδενοσίνης Α2A σε άνθρωπο που υποβάλλεται σε απεικόνιση μυοκαρδίου όπως επίσης και φαρμακευτικές συνθέσεις που περιλαμβάνουν τουλάχιστον έναν αγωνιστή υποδοχέα Α2A, τουλάχιστον ένα υγρό όχημα, και τουλάχιστον έναν συνδιαλύτη.
Patent CY-1115805-T1 (CY)
Title: Συντηρηση και ελεγχομενη παροχη/απελευθερωση σπερματοζωαριων
Inventor: KOMMISRUD ELISABETH
IPC: A01N1/02
Filed: 2014-12-03
Abstract: Η παρούσα εφεύρεση σχετίζεται με σωματίδια βιοπολυμερούς για συντήρηση σπερματοζωαρίων, όπου τα σπερματοζωάρια είναι εγκλεισμένα εντός του σωματιδίου βιοπολυμερούς. Η παρούσα εφεύρεση επίσης αφορά μία μέθοδο για συντήρηση, αποθήκευση και ελεγχόμενη παροχή/απελευθέρωση σπερματοζωαρίων, και τη χρήση των σωματιδίων βιοπολυμερούς σύμφωνα με την παρούσα εφεύρεση σε αναπαραγωγή.
Patent CY-1120951-T1 (CY)
Title: Ανθρωπινα αντισωματα enanti-tau
Inventor: CHEN FENG
IPC: C07K16/18
Filed: 2018-11-01
Abstract: Παρέχονται ανθρώπινα tau-ειδικά αντισώματα, όπως επίσης θραύσματα, παράγωγα και παραλλαγές αυτών, όπως επίσης μέθοδοι σχετικές με αυτά. Αποκαλύπτονται επίσης προσδιορισμοί, κιτ και στερεοί φορείς σχετικοί με τα ειδικά για την tau αντισώματα. Το αντίσωμα, αλυσίδα(ες) ανοσοσφαιρίνης, όπως επίσης θραύσματα δέσμευσης, παράγωγα και παραλλαγές αυτού, μπορούν να χρησιμοποιηθούν σε φαρμακευτικές και διαγνωστικές συνθέσεις για tau στοχευόμενη ανοσοθεραπεία και διάγνωση, αντίστοιχα.
Patent CY-1121223-T1 (CY)
Title: Ποντικοι οι οποιοι εκφραζουν ανθρωποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
Inventor: MACDONALD LYNN
IPC: C07K14/73
Filed: 2018-11-13
Abstract: Η εφεύρεση παρέχει γενετικώς τροποποιημένα μη-ανθρώπινα ζώα τα οποία εκφράζουν χιμαιρικά ανθρώπινα/μη-ανθρώπινα MHC I και MHC II πολυπεπτίδια και/ή ανθρώπινο ή ανθρωποποιημένο πολυπεπτίδιο 2 μικροσφαιρίνης, καθώς επίσης έμβρυα, κύτταρα και ιστούς που τα περιλαμβάνουν. Παρέχονται επίσης κατασκευάσματα για δημιουργία των εν λόγω γενετικώς τροποποιημένων ζώων και μέθοδοι δημιουργίας τους. Μέθοδοι χρήσης των γενετικώς τροποποιημένων ζώων για μελέτη διαφόρων απόψεων του ανθρώπινου ανοσοποιητικού συστήματος παρέχονται.
Patent CY-1121348-T1 (CY)
Title: Mrna θεραπεια για την θεραπευτικη αγωγη οφθαλμικων ασθενειων
Inventor: CALIAS PERICLES
IPC: C12N15/02
Filed: 2019-01-22
Abstract: Η παρούσα εφεύρεση παρέχει, μεταξύ άλλων πραγμάτων, μέθοδο οφθαλμικής απελευθέρωσης αγγελιοφόρου RNA (mRNA), περιλαμβάνουσα χορήγηση εντός του οφθαλμού ενός υποκειμένου που έχει ανάγκη απελευθέρωσης μιας σύνθεσης που περιλαμβάνει mRNA που κωδικοποιεί πρωτεΐνη, έτσι ώστε η χορήγηση της σύνθεσης έχει ως αποτέλεσμα έκφραση της πρωτεΐνης που κωδικοποιείται με το mRNA στον οφθαλμό.
Patent CY-1123926-T1 (CY)
Title: Αντισωματα κατα της τρανσγλουταμινασης 2
Inventor: JOHNSON TIM
IPC: C07K16/40
Filed: 2021-01-11
Abstract: Η εφεύρεση παρέχει αντισώματα και αντιγονοδεσμευτικά θραύσματα αυτών που δεσμεύονται επιλεκτικά σε ένα επίτοπο εντός της περιοχής πυρήνα της τρανσγλουταμινάσης τύπου 2 (TG2). Παρέχονται καινοτόμοι επίτοποι εντός του πυρήνα της TG2. Η εφεύρεση παρέχει αντισώματα αναστολής της ανθρώπινης TG2 και χρήσεις αυτών, ιδίως στην ιατρική, για παράδειγμα στη θεραπεία ή/και στη διάγνωση παθήσεων που συμπεριλαμβάνουν την κοιλιοκάκη, την ουλοποίηση, νόσους σχετιζόμενες με ίνωση, νευροεκφυλιστικές/νευρολογικές νόσους και καρκίνο.
Patent CY-1124571-T1 (CY)
Title: Ενεσιμες μικροπορωδεις υδροπηκτες
Inventor: BROGUIERE NICOLAS
IPC: A61L27/18
Filed: 2021-08-18
Abstract: Η εφεύρεση σχετίζεται με μια μέθοδο για την παραγωγή μιας μακροπορώδους υδροπηκτής. Σε ένα πρώτο στάδιο, ένα υδατικό διάλυμα δύο διαλυμένων ουσιών παράγεται. Η πρώτη διαλυμένη ουσία είναι ένα πολυμερές που μπορεί να συνδεθεί με σταυροειδείς δεσμούς και είναι ένα παράγωγο πολυαιθυλενογλυκόλης (PEG) ή πολυοξαζολίνης (ΡΟx) και η δεύτερη διαλυμένη ουσία είναι ένας κοσμοτροπικός παράγοντας. Σε ένα δεύτερο στάδιο, ένα παράγοντας σύνδεσης με σταυροειδείς δεσμούς προστίθεται στο διάλυμα. Αυτό ξεκινά ταυτόχρονα την πηκτωμάτωση του πολυμερούς και το διαχωρισμό των φάσεων, δημιουργώντας έτσι μια μακροπορώδη υδροπηκτή. Η εφεύρεση σχετίζεται περαιτέρω με μια μακροπορώδη υδροπηκτή, η οποία μπορεί να ληφθεί με την εφευρετική μέθοδο. Αυτή η μακροπορώδης υδροπηκτή αποτελείται από ένα συνδεδεμένο με σταυροειδείς δεσμούς πολυμερές, το οποίο είναι ένα παράγωγο πολυαιθυλενογλυκόλης (PEG) ή πολυοξαζολίνης (ΡΟx). Η υδροπηκτή παρουσιάζει διασυνδεδεμένους μακροπόρους με μέγεθος από 200 nm έως 1000 μm, συγκεκριμένα 500 nm έως 100 μm και χαρακτηρίζεται από ένα pΗ του 7,0 έως 8,0, συγκεκριμένα περίπου 7,4.
Patent HR-P20090390-T1 (HR)
Title: Inhibitors of the mutant form of kit
Inventor: BUCHDUNGER ELISABETH
IPC: A61P35/02
Filed: 2009-07-08
Abstract: The present invention relates to the treatment of KIT dependent diseases that are characterized by a mutant form of KIT whereby the mutant KIT is identified and an appropriate inhibitor of the mutant KIT is administered.
Patent HR-P20090652-T1 (HR)
Inventor: BAQUE NURIA BUSQUETS
IPC: C07D453/02
Filed: 2009-12-08
Abstract: Postupak proizvodnje 3(R)-(2-hidroksi-2,2-ditien-2-ilacetoksi)-1-(3-fenoksipropil)-1-azoniabiciklo[2.2.2]oktan bromida reakcijom 2-hidroksi-2,2-ditien-2-iloctena kiselina 1-azabiciklo[2.2.2]okt-3(R)-il estera i 3-fenoksipropil bromida, naznačen time, da se reakcija odvija u otapalu ili smjesama otapala gdje je točka ključanja između 50 i 210°C i odabrana je iz skupine koja se sastoji od ketona i cikličkih etera. Patent sadrži još 11 patentnih zahtjeva.
Patent HR-P20110241-T1 (HR)
Title: Vegetable fat blend and edible products containing such a fat blend
Inventor: ZIEVERINK MARTINUS MATHILDA PIETER
IPC: A23L33/00
Filed: 2011-04-04
Abstract: The present invention relates to a frying fat composition comprising at least 70 wt.% of refined fat and 5 - 100 mg/kg, preferably from 6 - 50 mg/kg of ß-carotene. This frying fat composition enables the preparation of high quality fried foodstuffs using shortened frying times. By decreasing frying times, acrylamide content of the final fried product can be reduced substantially.ß
Patent SI-1151007-T1 (SI)
Title: A method for producing a preparation based on fibrinogen and fibronectin as well as protein compositions obtainable according to this method
Inventor: SEELICH THOMAS
IPC: C07K14/00
Filed: 2000-02-10
Abstract: A method for producing protein compositions comprising fibrinogen and fibronectin is disclosed, wherein a fibrinogen and fibronectin-containing starting solution is treated with a precipitating composition which comprises two different components that modify the solubility of fibrinogen and/or fibronectin, so that in a single-step precipitation a precipitate is formed which comprises fibrinogen and fibronectin, and the precipitate formed optionally is further treated by methods known per se.
Patent SI-1223598-T1 (SI)
Title: Contact system for electromagnetic relay
Inventor: OBERNDORFER JOHANNES
IPC: H01H50/64
Filed: 2002-01-09
Abstract: The system has at least two closure elements, further contact and actuator arrangement. Each closure element has its own actuator driven by a relay armature, the movable part of each closure element is positively coupled to the associated actuator in the contact opening direction and both actuators are positively coupled to the movable part of the further contact only in the direction towards the operating position. The system has at least two closure elements (10,20), a further contact (30) and an actuator arrangement with at least two parallel movable components that closes both closure elements and the further contact by moving a relay armature into its operating position and opens both closure elements by returning the armature to its rest position, but prevents restoration of the further contact if one closure element does not open. Each closure element has its own actuator (40,50) driven by the relay armature, the movable part of each closure element is positively coupled to the associated actuator in the contact opening direction and both actuators are positively coupled to the movable part (35) of the further contact only in the direction towards the operating position.
Patent SI-1296214-T1 (SI)
Title: Method for activating a control unit mounted in a housing protected against unauthorised data access
Inventor: GAUSELMANN PAUL
IPC: A63F13/40
Filed: 2002-08-20
Abstract: A secure first memory contains a boot program and a decryption key. When the gaming device, such as a stand-alone slot machine, is switched on, the boot program is used to download a start program from an external memory into a main memory. The start program contains a decryption algorithm. The start program is then used to download an encrypted gaming program from the external memory. The start program decrypts the gaming program using the code key from the first memory and stores the decrypted gaming program in the main memory. A main processor then carries out the gaming program when a player initiates play of the gaming device. Because of the special sequence of all steps to load the data, an unauthorized person cannot load different or changed programs to any of the memories.
Patent SI-1722636-T1 (SI)
Title: Fungal lipolytic enzymes
Inventor: BRUNSTEDT JANNE
IPC: A23L15/10
Filed: 2005-03-10
Abstract: A fungal wild-type lipolytic enzyme having a higher ratio of activity on polar lipids compared with triglycerides, wherein the enzyme preferably has a phospholipid:triglyceride hydrolysing activity ratio of at least 4. Preferably, the lipolytic enzyme according to the present invention has a glycolipid:triglyceride hydrolysing activity ratio of at least 1.5. In one embodiment, the fungal lipolytic enzyme according to the present invention comprises an amino acid sequence as shown in SEQ ID No. 1 or SEQ ID No. 2 or SEQ ID No. 4 or SEQ ID No. 6 or an amino acid sequence which has at least 90% identity thereto. The present invention further encompasses a nucleic acid encoding a fungal lipolytic enzyme, which nucleic acid is selected from the group consisting of: (a) a nucleic acid comprising a nucleotide sequence shown in SEQ ID No. 3, SEQ ID No. 5 or SEQ ID No. 7; (b) a nucleic acid which is related to the nucleotide sequence of SEQ ID No. 3, SEQ ID No. 5 or SEQ ID No. 7 by the degeneration of the genetic code; and (c) nucleic acid comprising a nucleotide sequence which has at least 90% identity with the nucleotide sequence shown in SEQ ID No. 3, SEQ ID No. 5 or SEQ ID No. 7.
Patent SI-1700812-T1 (SI)
Title: Stairlift comprising a stabilization device
Inventor: HAWLE ENGELBERT
IPC: B66B9/00
Filed: 2006-03-06
Abstract: Stabilization device has conversion factor. Conversion factor, between spacing of pipe axle in millimeter and tilt angle of track, has value 1.2 to 5 millimeter per angle opposite to the horizontal, for each spacing between axle of lower and upper track pipe, 200 to 500 millimeter in horizontal span, 0 to 90 degree in inclined span of track. Transformation or transfer factor is amounts to 1.97 to 5 between the geared part (2) and the gear ring (21).
Patent SI-1851319-T1 (SI)
Title: Vectors, cell lines and their use in obtaining extended episomal maintenance replication of hybrid plasmids and expression of gene products
Inventor: SILLA TOOMAS
IPC: C12N15/00
Filed: 2006-02-13
Abstract: This disclosure shows that the BPV-1 E2 protein-dependent minichromosome maintenance element (MME) comprised of E2 multimeric binding sites can provide the stable maintenance replication function to the mouse polyomavirus (PyV) core origin plasmids in the presence of BPV-1 E2 protein and PyV large T-antigen (LT). MME dependent plasmids are lost with the frequency of 6% per generation. Significantly long stable maintenance replication can also be provided without selection pressure. We also demonstrate that PyV core origin maintenance function/replication activation could be provided by Epstein-Barr virus Family of repeats and EBNA1 protein. The maintenance of the Polyomavirus core origin plasmid was characterized by 13% loss of the plasmid during one cell generation in the case of EBV FR harboring plasmids. Our data clearly indicate that maintenance functions from different viruses can provide segregation/partitioning function to different heterologous origins in variety of cells and can be used in expression of gene products.
Patent SI-2424569-T1 (SI)
Title: Anti-mesothelin immunoconjugates and uses thereof
Inventor: KAHNERT ANTJE
IPC: A61P35/00
Filed: 2010-04-16
Abstract: The present invention provides immunoconjugates composed of antibodies, e.g., monoclonal antibodies, or antibody fragments that bind to mesothelin, that are conjugated to cytotoxic agents, e.g., maytansine, or derivatives thereof, and/or co-administered or formulated with one or more additional anti-cancer agents. The immunoconjugates of the invention can be used in the methods of the invention to treat and/or diagnose and/or monitor cancers, e.g. solid tumors, recombinant antigen-binding regions and antibodies and functional fragments containing such antigen-binding regions that are specific for the membrane-anchored, 40 kDa mesothelin polypeptide, which which is overexpressed in several tumors, such as pancreatic and ovarian tumors, mesothelioma and lung cancer cells.
Patent SI-2524060-T1 (SI)
Title: Assay for jc virus antibodies
Inventor: GORELIK LEONID
IPC: G01N33/00
Filed: 2011-01-11
Abstract: The disclosure relates to methods and reagents for analyzing samples for the presence of JC virus antibodies. Disclosed is a method that includes obtaining a biological sample from a subject (e.g., plasma, serum, blood, urine, or cerebrospinal fluid), contacting the sample with highly purified viral-like particles HPVLPs) under conditions suitable for binding of a JCV antibody in the sample to an HPVLP, and detecting the level of JCV antibody binding in the sample to HPVLP In one embodiment, determining the level of anti-JCV antibodies in the subject sample provides a method of identifying PML risk in a subject.
Patent SI-2815404-T1 (SI)
Title: Integral molten salt reactor
Inventor: LEBLANC DAVID
IPC: G21C17/00
Filed: 2013-02-06
Abstract: The present relates to the integration of the primary functional elements of graphite moderator and reactor vessel and/or primary heat exchangers and/or control rods into an integral molten salt nuclear reactor (IMSR). Once the design life of the IMSR is reached, for example, in the range of 3 to 10 years, it is disconnected, removed and replaced as a unit. The spent IMSR functions as the medium or long term storage of the radioactive graphite and/or heat exchangers and/or control rods and/or fuel salt contained in the vessel of the IMSR.
Patent DE-3752331-T2 (DE)
Inventor: EWEN JOHN A
IPC: C08F4/64
Filed: 1987-09-21
Granted: 2001-09-20
Abstract: The invention provides a process for pre-polymerizing olefin polymerization catalysts and a process for increasing the efficiency of pre-polymerized olefin polymerization catalysts. In one process of this invention an olefin monomer is added to a fluid carrier stream containing an olefin polymerization catalyst. The carrier stream containing the monomer and the catalyst is passed through an elongated tubular reactor at a flow rate sufficient to provide a residence time in the tubular reactor of less than 1 minute and under temperature conditions to pre-polymerize the catalyst within the tubular reactor without plugging of the reactor. In another process of this invention a pre-polymerized catalyst is contacted with a cocatalyst or a mixture of cocatalyst and an electron donor prior to introducing the catalyst into a polymerization reaction zone. <IMAGE>
Patent DE-3779753-T2 (DE)
Inventor: LIU CHI-LI
IPC: C12N9/52
Filed: 1987-11-25
Granted: 1992-12-10
Abstract: PCT No. PCT/DK87/00144 Sec. 371 Date Aug. 30, 1988 Sec. 102(e) Date Aug. 30, 1988 PCT Filed Nov. 25, 1987 PCT Pub. No. WO88/03947 PCT Pub. Date Jun. 2, 1988.Novel alkaline serine proteases produced by Nocardiopsis sp. strains, for example by aerobic cultivation of strain 10R (NRRL-18262) and Nocardiopsis dassonvillei strain M58-1 (NRRL 18133), the proteases being characterized by a pH optimum of about 8, and by retention of at least 60% of maximum activity at pH 7-11 measured with casein as substrate. The proteases of the invention may be distinguished from the known protease of the Nocardiopsis strain ZIMET 43647 (of East German 2004328) and known Bacillus and fungal alkaline proteases. The Alkaline proteases of strains 10R and M58-1 may also be distinguished from each other. The protease preparations of this invention are useful detergent additives for cold water laundering.
Patent DE-3789619-T2 (DE)
Inventor: DIGIANFILIPPO ALEANDRO
IPC: G05D11/13
Filed: 1987-11-30
Granted: 1994-10-13
Abstract: A transfer set for use in an automatic compounding device comprises a manifold (67) having a plurality of connector conduits (68) a plurality of inlet tubes (43) connected to respective connector conduits. The manifold opens into a measuring chamber (18) which leads to a single outlet tube (22). Each inlet tube (43) communicates with a respective source container (12) through a spike (40). The measuring chamber is suspended from a load cell, in use. A differential pressure source is connected through a pressure conduit (26) to one of the connector conduits (68) for effecting fluid flow from selected source containers into the chamber (18) and fluid flow from the chamber through to outlet tube.
Patent DE-3871922-T2 (DE)
Inventor: CANNELLI GIOVANNI BOSCO
IPC: G10K11/28
Filed: 1988-12-05
Granted: 1992-12-03
Abstract: An echographic technique-based method for prospectings of the subsoil or sea bottom and the like, by means of acoustic waves and carried out by the use of an apparatus constitued, in combination of a known acoustic wave transmittings equipment (1) consisting of a body (6, 8) in the inside of which a chamber (9) is formed defined by an internal reflecting surface (7) shaped like a round paraboloid of axis (Y-Y), closed at the base by an elastic diaphragm (5) and filled with a proper liquid, into which acoustic waves are emitted produced by a pair of main electrodes (10a, 10b) associated with an auxiliary discharge priming electrode (11) put between the first ones. The equipment (1) will be installed at a predetermined distance "D" from a receiving equipment (2) having a body structure (6a, 8) substantially like to that of the equipment (2), but that near the focus of its internal paraboloidic reflecting surface (7) has a piezoelectric - ceramic detector (13) mounted on the lower end of a hollow rod supported by the head (6a) of said body, by means allowing said detector (13) to be moved into the chamber (9) with respect to the focus within a range of predetermined value in any direction.
Patent DE-3879188-T2 (DE)
Inventor: GABRILOVE L
IPC: C07K14/535
Filed: 1988-11-16
Granted: 1993-08-26
Abstract: This invention provides method of preventing mucositis in a subject susceptible to mucositis comprising administering to the subject a prophylactically effective amount of granulocyte colony stimulating factor or a polypeptide analog thereof having substantially the same amino acid sequence and the activity of naturally occurring granulocyte colony stimulating factor. This invention further provides a method of treating mucositis in a subject having mucositis comprising administering to the subject a therapeutically effective amount of granulocyte colony stimulating factor or a polypeptide analog thereof having substantially the same amino acid sequence and the activity of naturally occurring granulocyte colony stimulating factor.
Patent DE-60004375-T2 (DE)
Inventor: MALMGREN KENT
IPC: A61F13/53
Filed: 2000-08-23
Granted: 2004-06-24
Abstract: The invention refers to an absorbent structure in an absorbent article such as a diaper, a pant diaper, an incontinence guard, a sanitary napkin etc., the absorbent structure comprises an open-cell foam structure, the pore walls of said foam structure comprising a liquid-storing material having the capacity to store more than 7% synthetic urine defined according to the CRC method. The absorbent structure is characterized by that the pores of the foam structure contains hydrophilic fibers, at which at least the main part of the hydrophilic fibers are firmly anchored in the pore walls of the foam structure, and that the fiber amount is at least 10% by weight of the total weight of the open-cell foam in dry condition. The invention also refers to an absorbent article containing such an absorbent structure.